CLS Investments »

Bicara Therapeutics shares owned by CLS Investments

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by CLS Investments from 13F filings

Historical chart of CLS Investments investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by CLS Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by CLS Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $179k 11k 15.79

More positions owned by CLS Investments

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Ishares Tr Core S&p500 Etf (IVV)
Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Index Fds Growth Etf (VUG)
Advisors Inner Circle Fd Ii 3edge Dynamic Fi (EDGF)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Total (IXUS)

View all positions for CLS Investments

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics